Archive: 2024 / 08
Eli Lilly's New Parkinson's Drug Shows Significant Promise in Clinical Trials
Eli Lilly’s experimental drug, LY344867, has shown notable success in a mid-stage clinical trial. The medication, aimed at slowing Parkinson's disease progression, revealed significant improvements in motor function among early-stage patients. Over 12 months, 180 patients participated, with those on LY344867 experiencing a 35% reduction in motor symptoms. The promising data was presented at a major medical conference.
Aug, 17 2024
Categories
- Health and Wellness (14)
- Health & Wellness (5)
- Health (4)
- Health and Medicine (3)
- Health and Nutrition (2)
- Legal (2)
- Earthquake Science and Research News (1)
- Women's Health and Pregnancy (1)
- Mental Health and Addiction Recovery (1)
- Health and Fitness (1)
Archives
- June 2025 (2)
- May 2025 (4)
- April 2025 (3)
- March 2025 (3)
- February 2025 (1)
- January 2025 (3)
- October 2024 (2)
- September 2024 (1)
- August 2024 (1)
- May 2024 (1)
- January 2024 (1)
- November 2023 (2)